Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people with type 2 diabetes, high blood pressure, and heart disease.
This study is enrolling at both Rochester & Buffalo locations.
Type 2 Diabetes, Heart & Blood Pressure Study
Age Range:
18
Gender:
Male and Female
Location:
Buffalo, New York
About the Study
The purpose of this study is to see if adding an investigational medicine to a commonly used diabetes medication may help lower the risk of serious heart problems, such as heart failure or heart-related death. Researchers will also look at how the treatment may affect blood pressure and kidney health.
This study will include regular health check-ins, lab tests, and study visits to help monitor your safety and how well the treatment is working over time.
Qualifications
You May Qualify if you are:
- 18 years or older
- Diagnosed with type 2 diabetes
- Have high blood pressure
- Have a history of heart or blood vessel disease (such as prior heart issues)
- Currently receiving standard medical care for these conditions
Other qualifications apply during screening.
FEATURED STUDIES
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study […]
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]